These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2365868)

  • 1. Facial telangiectasia and long-term corticosteroid use: a fallacy?
    Martin S
    J Am Acad Dermatol; 1990 Jul; 23(1):150. PubMed ID: 2365868
    [No Abstract]   [Full Text] [Related]  

  • 2. Facial telangiectasia associated with long-term application of a topical corticosteroid to the scalp.
    Hogan DJ; Rooney ME
    J Am Acad Dermatol; 1989 Jun; 20(6):1129-30. PubMed ID: 2754065
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible association of cutaneous telangiectasia with cardiac myxoma.
    Bridges BF; Hector DA
    Am J Med; 1989 Oct; 87(4):483-5. PubMed ID: 2801743
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiology and determinants of facial telangiectasia: a cross-sectional study.
    Mekić S; Hamer MA; Wigmann C; Gunn DA; Kayser M; Jacobs LC; Schikowski T; Nijsten T; Pardo LM
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):821-826. PubMed ID: 31593313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized cutaneous fusariosis after long-term topical application of corticosteroids in a healthy elderly woman.
    Yamada Y; Nishioka G; Makimura K; Oka M
    Eur J Dermatol; 2012; 22(4):555-9. PubMed ID: 22735127
    [No Abstract]   [Full Text] [Related]  

  • 6. Ocular side-effects of topical corticosteroids: what a dermatologist needs to know.
    Daniel BS; Orchard D
    Australas J Dermatol; 2015 Aug; 56(3):164-9. PubMed ID: 25754554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid-induced atrophy of the skin with telangiectasia. A clinical and experimental study.
    Stevanović DV
    Br J Dermatol; 1972 Dec; 87(6):548-56. PubMed ID: 4648801
    [No Abstract]   [Full Text] [Related]  

  • 8. Facial telangiectasia: an unusual manifestation of neonatal lupus erythematosus.
    Guinovart RM; Vicente A; Rovira C; Suñol M; González-Enseñat MA
    Lupus; 2012 Apr; 21(5):552-5. PubMed ID: 22170760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of previous topical corticosteroid on patch testing.
    Green C
    Contact Dermatitis; 2007 May; 56(5):300. PubMed ID: 17441868
    [No Abstract]   [Full Text] [Related]  

  • 10. [Topical corticosteroid induced changes in the cutaneous basal lamina: scanning electron microscopy study].
    Sheu HM; Yu HS
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1986 Aug; 2(8):502-7. PubMed ID: 3482698
    [No Abstract]   [Full Text] [Related]  

  • 11. Complications of topical corticosteroid therapy.
    Baer RL; Myrow R
    Arch Belg Dermatol Syphiligr; 1970; 26(2):129-44. PubMed ID: 4252344
    [No Abstract]   [Full Text] [Related]  

  • 12. Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats.
    Smith JG; Wehr RF; Chalker DK
    Arch Dermatol; 1976 Aug; 112(8):1115-7. PubMed ID: 952530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facial what?
    Collins SS
    Nurs Spectr (Wash D C); 1999 Jan; 9(1):18. PubMed ID: 10542798
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistent telangiectasia following patch testing with topical corticosteroids.
    Sommer S; Wilkinson SM; Sheehan-Dare R
    Contact Dermatitis; 2000 Nov; 43(5):306. PubMed ID: 11016674
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cutaneous manifestations in general long term corticosteroid therapy].
    Martín-Pascual A; De Unamuno P; Asensio A
    Actas Dermosifiliogr; 1977; 68(12):63-74. PubMed ID: 140595
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse side-effects after topical fluorinated corticosteroid therapy.
    Chernosky ME; Schmidt JD
    Arch Dermatol; 1973 Jul; 108(1):132-3. PubMed ID: 4716732
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement.
    Mooney E; Rademaker M; Dailey R; Daniel BS; Drummond C; Fischer G; Foster R; Grills C; Halbert A; Hill S; King E; Leins E; Morgan V; Phillips RJ; Relic J; Rodrigues M; Scardamaglia L; Smith S; Su J; Wargon O; Orchard D
    Australas J Dermatol; 2015 Nov; 56(4):241-51. PubMed ID: 25752907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of atrophy of human skin caused by corticosteroids using chamber occlusion and suction blister techniques.
    Somerma S; Lassus A; Salde L
    Acta Derm Venereol; 1984; 64(1):41-5. PubMed ID: 6203280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growing nodule with telangiectasia on the scalp.
    Olsavszky V; Géraud C
    J Dtsch Dermatol Ges; 2020 May; 18(5):501-504. PubMed ID: 31846198
    [No Abstract]   [Full Text] [Related]  

  • 20. [Corticosteroids: topical cutaneous. Principles and rules of use, posology].
    Bonnetblanc JM
    Rev Prat; 1992 Dec; 42(20):2609-13. PubMed ID: 1299950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.